REGENXBIO Inc.
RGNX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001590877
In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 0 sales; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding REGENXBIO Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 175 | 167 | −8 |
| Shares | 37.0M | 37.1M | +155.5K (+0.4%) |
| Value | $700.0M | $742.1M | +$42.0M (+6.0%) |
New holders (15)
Institutions that held REGENXBIO Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cubist Systematic Strategies, LLC | 97,259 | $1.94M | 0.02% |
| Jump Financial, LLC | 47,697 | $953.5K | 0.04% |
| Boulder Hill Capital Management LP | 35,396 | $707.6K | 1.36% |
| Renaissance Technologies LLC | 27,700 | $554.0K | 0.00% |
| Verition Fund Management LLC | 20,158 | $403.0K | 0.01% |
| HRT Financial LP | 18,939 | $378.0K | 0.00% |
| Cresset Asset Management, LLC | 17,270 | $345.2K | 0.00% |
| Point72 Middle East FZE | 15,014 | $300.1K | 0.02% |
| Cornercap Investment Counsel Inc | 12,074 | $241.4K | 0.04% |
| Headlands Technologies LLC | 2,204 | $44.1K | 0.01% |
| Massmutual Trust Co FSB | 329 | $6.58K | 0.00% |
| Glassman Wealth Services | 180 | $3.60K | 0.00% |
| Signaturefd, LLC | 18 | $360 | 0.00% |
| Sofos Investments, Inc. | 20 | $248 | 0.00% |
| Point72 Asset Management, L.P. | 7 | $140 | 0.00% |
Sold out (23)
Institutions that held REGENXBIO Inc. at the end of Q1 2023 and filed for Q2 2023 without it.